Remaining RLDs from pilot study- retention sample? [Regulatives / Guidelines]

posted by dshah  – India, 2023-10-03 19:27 (597 d 22:59 ago) – Posting: # 23735
Views: 3,262

Dear QA and RK!


❝ What if sponsor sent 1 bottle containing 56 tabs. of RLD to CRO for pilot study from which only 12 tabs. were utilized. Can rest of the tablets be used for pivotal study from the same opened bottle of RLD? Of course storage conditions were maintained in pharmacy of CRO.


Mostly you would not be able to use for below reasons.
- Does the remaining quantity is sufficient for testing or will you have sufficient retention samples? Generally the RLD samples are directly shipped to CRO and thus sponsor's may not have sufficient quantity of retention samples.

Regards,
Divyen Shah

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,680 registered users;
46 visitors (0 registered, 46 guests [including 30 identified bots]).
Forum time: 18:27 CEST (Europe/Vienna)

Pharmacokinetics may be simply defined as
what the body does to the drug,
as opposed to pharmacodynamics, which may be defined as
what the drug does to the body.    Leslie Z. Benet

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5